From these, 410 patients were excluded for the following reasons (Figure 1): 93 cases because they had no the detection of ALK rearrangement; 311 patients were not in the stage IV; 2 patients had no the detection of serum tumor markers; four patients recorded the levels of tumor markers after anticancer therapy. Here, ALK is linked to neoplasm.